60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

12 trials found

diseases per page:

Showing 1 to 10 of 12 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03173937 (ClinicalTrials.gov)	June 13, 2017	31/5/2017	Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using ...	Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using ...	Severe Aplastic Anemia;Hypo-Plastic MDS;Myelodysplastic Syndrome (MDS)	Biological: Omidubicel (former CordIn)	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Recruiting	4 Years	75 Years	All	37	Phase 1/Phase 2	United States
2	NCT01553461 (ClinicalTrials.gov)	February 21, 2012	13/3/2012	Transplants With Unlicensed Preserved Cord Blood	A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) ...	Myelodysplastic Syndrome (MDS);Hematologic Neoplasms;Hematologic Diseases;Severe Aplastic Anemia	Biological: Cord Blood Transplant	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Recruiting	4 Years	99 Years	All	500	Phase 1/Phase 2	United States
3	NCT01500161 (ClinicalTrials.gov)	November 2011	18/11/2011	Pooled Unrelated Donor Umbilical Cord Blood TransplantFor Hematologic Malignancy Needing Allogeneic ...	A Phase II Study Of Pooled Unrelated Donor Umbilical Cord Blood (UCB) Transplant For Patients With H ...	Acute Myelogenous Leukemia;Acute Lymphocytic Leukemia;Chronic Lymphocytic Leukemia;Chronic Myelogeno ...	Drug: Busulfan;Drug: Clofarabine;Drug: Fludarabine;Drug: Melphalan;Drug: Carmustine;Drug: Etoposide; ...	Texas Oncology Cancer Center	NULL	Terminated	18 Years	65 Years	Both	1	Phase 2	United States
4	JPRN-UMIN000004264	2010/11/01	01/11/2010	A Pharmacokinetics (PK)/Phase I study of intravenous (i.v.) administration of mycophenolate mofetil ...	A Pharmacokinetics (PK)/Phase I study of intravenous (i.v.) administration of mycophenolate mofetil ...	Refractory hematologic disorders, including1. Acute myelogenous leukemia2. Acute lymphoblastic leuke ...	For GVHD prophylaxis, MMFis administered 4-6 h after allo-SCT at a dose of 1000 mg i.v. (diluted to ...	Kobe University Graduate School of Medicine	School of Pharmacy and Pharmaceutical Science, Mukogawa Women's University	Complete: follow-up complete	15years-old	69years-old	Male and Female	10	Phase 1	Japan
5	EUCTR2007-001657-26-GB (EUCTR)	29/02/2008	07/11/2007	Single Centre Phase II Pilot study of Unrelated Cord Blood Transplantation in Patients with Poor Ris ...	Single Centre Phase II Pilot study of Unrelated Cord Blood Transplantation in Patients with Poor Ris ...	1.Acute, chronic leukaemia or myelodysplastic syndrome for which allogeneic transplantation is consi ...	Trade Name: Fludarabine INN or Proposed INN: FLUDARABINE PHOSPHATE Trade Name: Busilvex INN or Proposed ...	King's College Hospital NHS Foundation Trust	NULL	Not Recruiting			Female: yes Male: yes	27	Phase 2	United Kingdom
6	NCT00673114 (ClinicalTrials.gov)	August 2007	27/12/2007	Unrelated Cord Blood TransplantPlus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplan ...	A Prospective, Phase I/II Trial Determining the Efficacy and Safety of Allogeneic Hematopoietic Stem ...	Hematologic Malignancy;Myelodysplastic Syndrome (MDS);Aplastic Anemia	Biological: haplo/cord transplant	Joanne Kurtzberg, MD	Miltenyi Biotec GmbH	Completed	N/A	55 Years	All	3	Phase 1/Phase 2	United States
7	NCT00354419 (ClinicalTrials.gov)	February 2006	19/7/2006	Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Sever ...	A Dose Finding Study of Total Body Irradiation for Conditioning Patients With Severe Aplastic Anemia ...	Aplastic Anemia	Radiation: total-body irradiation;Drug: cyclophosphamide;Biological: anti-thymocyte globulin;Drug: c ...	Fred Hutchinson Cancer Research Center	National Cancer Institute (NCI)	Terminated	N/A	40 Years	Both	30	Phase 1	United States
8	NCT00676806 (ClinicalTrials.gov)	July 2005	9/5/2008	A Phase II Study of Umbilical Cord Blood Transplantation	A Phase II Study of Umbilical Cord Blood Transplantation Following Myeloablative or Reduced-Intensit ...	Leukemia;Lymphoma;Multiple Myeloma;Aplastic Anemia	Biological: Umbilical Cord Blood After Myeloablative Conditioning;Biological: Umbilical Cord Blood A ...	Tufts Medical Center	NULL	Terminated	N/A	70 Years	All	7	Phase 2	United States
9	NCT00054236 (ClinicalTrials.gov)	May 2002	5/2/2003	Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With ...	Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Condit ...	Chronic Myeloproliferative Disorders;Leukemia;Lymphoma;Multiple Myeloma and Plasma Cell Neoplasm;Mye ...	Biological: anti-thymocyte globulin;Biological: filgrastim;Drug: cyclophosphamide;Drug: fludarabine p ...	Case Comprehensive Cancer Center	NULL	Completed	N/A	120 Years	All	55	Phase 1	United States
10	NCT00053989 (ClinicalTrials.gov)	January 29, 2002	5/2/2003	NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders	Non-Myeloablative Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation for Hematologi ...	Chronic Myeloproliferative Disorders;Leukemia;Lymphoma;Multiple Myeloma and Plasma Cell Neoplasm;Mye ...	Biological: anti-thymocyte globulin;Biological: graft-versus-tumor induction therapy;Biological: sar ...	Roswell Park Cancer Institute	NULL	Completed	4 Years	75 Years	All	41	Phase 2	United States

First Previous1 2Next Last